Status:
ACTIVE_NOT_RECRUITING
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Brigham and Women's Hospital
Conditions:
Hodgkin's Disease
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The main purpose of this study is to determine if it is possible to put into practice a cardiac screening program for survivors of Hodgkin's disease. In this study, we would also like to screen for ca...
Detailed Description
* On the day of the patient's scheduled follow-up visit with their oncologist, additional blood work will be obtained and the patient will fill out questionnaires concerning their general health and a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients treated at Brigham and Women's Hospital or Dana-Farber Cancer Institute for Hodgkin's disease with mediastinal irradiation
- Age \> or = to 15 years of age
- Five years or longer after initial treatment
- Relapse-free interval of \> 1 year
- Exclusion criteria:
- Patients treated for Hodgkin's disease outside of Brigham and Women's Hospital or Dana-Farber Cancer Institute
- Current age \< 15 years of age
- Less than 5 years out from initial treatment
- Relapses within 1 year
Exclusion
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2028
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00165425
Start Date
February 1 2004
End Date
December 1 2028
Last Update
September 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115